Q-omics provides the consensus-scored RNA5SP444 profile across patient tissues and cancer cell-line models. RNA5SP444 expression is associated with patient survival in 6 of 34 cancer types, with the highest sampling consensus in GBM. Additionally, RNA5SP444 RNA expression shows 5,853 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight GBM, and STAD as cancer lineages where RNA5SP444 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.